Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
Our Research Team Covers 300 Companies Across 24 Sectors

STOCK RECOMMENDATION

Search a Stock
Sectors
Sort by
Sort by
Clear
  • Reco Date
  • Reco price
  • Earning growth
Reco Date
 Stock Name
 sector
 View
 Reco Price
 Earning Growth
(2 year expected CAGR)		 Forward P/E

The price to earnings ratio (P/E) measures the market’s valuation of a company relative to its annual net profits

 Read Report
Oct 31, 2025 Cipla Pharmaceuticals
Jul 28, 2025 Cipla Pharmaceuticals
May 14, 2025 Cipla Pharmaceuticals
Nov 4, 2024 Cipla Pharmaceuticals
May 17, 2024 Cipla Pharmaceuticals
Oct 30, 2023 Cipla Pharmaceuticals
Sep 12, 2023 Cipla Pharmaceuticals
Jul 27, 2023 Cipla Pharmaceuticals
Cipla
Pharmaceuticals
Reco Price (Oct 31, 2025) 1,540.00
Forward P/E 23.77
Earning Growth (2 YR expected CAGR) -0.46 %
overweight
Cipla
Pharmaceuticals
Reco Price (Jul 28, 2025) 1,532.00
Forward P/E 22.63
Earning Growth (2 YR expected CAGR) 1.74 %
overweight
Cipla
Pharmaceuticals
Reco Price (May 14, 2025) 1,520.00
Forward P/E 25.59
Earning Growth (2 YR expected CAGR) 7.82 %
overweight
Cipla
Pharmaceuticals
Reco Price (Nov 4, 2024) 1,478.00
Forward P/E 28.05
Earning Growth (2 YR expected CAGR) 4.96 %
overweight
Cipla
Pharmaceuticals
Reco Price (May 17, 2024) 1,340.00
Forward P/E 26.22
Earning Growth (2 YR expected CAGR) 18.86 %
equalweight
Cipla
Pharmaceuticals
Reco Price (Oct 30, 2023) 1,174.00
Forward EV/EBITDA 14.70
Earning Growth (2 YR expected CAGR) 16.70 %
equalweight
Cipla
Pharmaceuticals
Reco Price (Sep 12, 2023) 1,247.00
Forward EV/EBITDA 17.00
Earning Growth (2 YR expected CAGR) 13.79 %
equalweight
Cipla
Pharmaceuticals
Reco Price (Jul 27, 2023) 1,069.00
Forward P/E 25.27
Earning Growth (2 YR expected CAGR) 13.78 %
overweight
Search a Stock
Sectors
Sort by
Sort by
Clear
  • Reco Date
  • Reco price
  • Exit Price
  • Exit Date
  • Returns
Reco Date
 Stock Name
 Sector
 Reco Price
 Exit Price
 Exit Date
 Last Recommendation
 Returns
May 17, 2021 Cipla Pharmaceuticals 904.00 1,155.00 Nov 7, 2022 overweight 27.77 %
May 18, 2020 Cipla Pharmaceuticals 570.00 826.00 Jan 30, 2021 overweight 44.91 %
Cipla
Pharmaceuticals
Reco Price (May 17, 2021) 904.00
Last Recommendation overweight
Exit Price (Nov 7, 2022) 1,155.00
Returns: 27.77 %
Cipla
Pharmaceuticals
Reco Price (May 18, 2020) 570.00
Last Recommendation overweight
Exit Price (Jan 30, 2021) 826.00
Returns: 44.91 %
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347